SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

PRA Health Sciences launches major early phase expansions

In another sign that early phase research demand is picking up, North Carolina-based CRO PRA Health Sciences (PRA) is increasing its Phase I clinical footprint in the US and Russia. 

News in brief

CFDA accepts WuXi-MedImmune’s IND for new mAb

The China Food and Drug Administration (CFDA) has accepted for review an Investigational New Drug (IND) application for WuXi and MedImmune's novel anti-IL6 monoclonal antibody (mAb) for rheumatoid arthritis. 

Slow study start-ups tied to local IRB use, expert says

As CROs (contract research organizations) and sponsors look to shave off time from their clinical trial start-up phase, which is where delays occur most frequently, companies may want to look away from local IRBs (institutional review boards), an expert told us.

Update

Quintiles, Quest Diagnostics launch JV merging lab services

With an eye on central labs industry leader LabCorp, Quintiles and Quest Diagnostics are combining their clinical trials lab operations to provide clients with the world’s second-largest option.

UK politician pledge would ban 89% of animal research, say scientists

British MPs have signed an anti-animal cruelty pledge which scientists warn would “cripple” disease research and outlaw 89% of preclinical animal research.

Ergomed opens new office in Taiwan to meet growing Asian demand

UK-based risk-sharing CRO Ergomed has opened its first Asian office in Taiwan to strengthen its clinical research and consultancy presence in Asia.

News in brief

Catalent buys Australian packaging company

Catalent has acquired Australian pharmaceutical packaging firm Pharmapak to complement its softgel business.

Spotlight

Outsourcing market’s recently IPO'd stock prices see early spike

Outsourcing market’s recently IPO'd stock prices see early spike

Between May 2013, when Quintiles went public , and this week, newly public companies’ stocks in the biopharma...

US FDA working to make clinical trials less wasteful

US FDA working to make clinical trials less wasteful

The US FDA is looking to set up master protocols that can continuously run and help cut...

Researchers enthusiastic over Obama’s new $215m precision medicine initiative

Researchers enthusiastic over Obama’s new $215m precision medicine initiative

In what was largely a pep rally for science, President Obama on Friday unveiled his $215m precision...

Strong USD to hit revenues but strategic CROs may see lower costs

Strong US Dollar to hit revenues but strategic CROs may see lower costs

The strengthening US Dollar will reduce CRO revenues, say analysts, but firms which have global strategic deals...

Biosimulation – the next step in PK modelling embraced by regulators

Biosimulation – the next step in PK modelling embraced by regulators

Computer-based drug modelling is moving from a discovery aid to a clinical tool accepted by regulators, according...